These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 6844674
1. [Changes in cholesterol transport by lipoproteins in patients with renal insufficiency]. Pérez A, Alegre B, Panadero J, Martín L, Breto M, Cruz JM. Rev Clin Esp; 1983 Jan 15; 168(1):13-6. PubMed ID: 6844674 [No Abstract] [Full Text] [Related]
2. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant. Sutherland WH, Corboy J, Walker RJ, Robertson MC, Ball MJ. Nephrol Dial Transplant; 1995 Jan 15; 10(3):358-65. PubMed ID: 7792031 [Abstract] [Full Text] [Related]
3. [Determination methods and clinical significance of HDL-cholesterol (author's transl)]. Fukui I. Rinsho Byori; 1981 Nov 15; 29(11):1071-8. PubMed ID: 7334659 [No Abstract] [Full Text] [Related]
4. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment. Albertazzi A, Capelli P, Di Paolo B, Pola P, Tondi P, Vaccario O. Proc Eur Dial Transplant Assoc; 1983 Nov 15; 19():302-7. PubMed ID: 6878245 [Abstract] [Full Text] [Related]
5. [The difficult road to cholesterol homeostasis]. Joossens JV. Verh K Acad Geneeskd Belg; 1984 Nov 15; 46(1):5-31. PubMed ID: 6331021 [No Abstract] [Full Text] [Related]
6. [Chronic kidney failure, hyperproteinemia and vascular risk]. Rubiés-Prat J. Med Clin (Barc); 1984 Jun 23; 83(4):173-5. PubMed ID: 6482569 [No Abstract] [Full Text] [Related]
8. Lipid and lipoprotein metabolism in chronic kidney disease. Kaysen GA. J Ren Nutr; 2009 Jan 23; 19(1):73-7. PubMed ID: 19121776 [Abstract] [Full Text] [Related]
9. Does atherosclerosis caused by dialysis limit this treatment? Kindler J, Sieberth HG, Hahn R, Glöckner WM, Vlaho M, Pelzer R. Proc Eur Dial Transplant Assoc; 1983 Jan 23; 19():168-74. PubMed ID: 6348734 [Abstract] [Full Text] [Related]
10. The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients. Jurek A, Turyna B, Kubit P, Klein A. Clin Biochem; 2008 Aug 23; 41(12):1015-8. PubMed ID: 18474235 [Abstract] [Full Text] [Related]
17. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W, Reuter W. Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
18. Cholesterol metabolism in patients with chronic renal failure on hemodialysis. Igel-Korcagova A, Raab P, Brensing KA, Pöge U, Klehr HU, Igel M, von Bergmann K, Sudhop T. J Nephrol; 2003 Dec 15; 16(6):850-4. PubMed ID: 14736012 [Abstract] [Full Text] [Related]
19. Role of mast cells in atherosclerosis. Kovanen PT. Chem Immunol; 1995 Dec 15; 62():132-70. PubMed ID: 7546279 [No Abstract] [Full Text] [Related]
20. In vivo exchange of cholesteryl esters from low density lipoproteins to high density lipoproteins. Nestel PJ, Billington T. Artery; 1980 Dec 15; 7(5):395-403. PubMed ID: 7213024 [Abstract] [Full Text] [Related] Page: [Next] [New Search]